Dr Agarwals Healthcare IPO
Company Overview
Established in 2010, Dr. Agarwal's Health Care Limited is a leading provider of comprehensive eye care services. The company offers a range of solutions, including surgical and non-surgical treatments, consultations, diagnostics, and the sale of optical products and pharmaceuticals. Service Portfolio
Dr. Agarwal's offers advanced eye care services, including:
Cataract Surgeries: Small incision, phacoemulsification, robotic, and glued intraocular lens procedures.
Refractive Surgeries: LASIK, SMILE, implantable collamer lenses, and PRK.
Specialized Surgeries: Retinal treatments, corneal transplants, pinhole phalloplasty, oculoplastics, glaucoma, and pterygium care.
Network and Presence
As of September 30, 2024, Dr Agarwal's operates an extensive network:
28 hubs (tertiary facilities, including three Centers of Excellence)
165 spokes (53 primary and 112 secondary facilities)
Presence in 117 cities across 14 states and 4 union territories through 193 facilities
Over 700 doctors providing expert care
Strengths
Largest network: 209 eye care centres in India.
Established leadership with a strong operational history.
Comprehensive service offerings, catering to diverse eye care needs.
Market leader with significant growth potential.
Risks
Dependence on regulatory approvals.
High competition within the market.
Financial risks and debt burden.
Exposure to legal challenges.
Dr Agarwals Healthcare IPO: Key Details
Dates: 29 to 31 January 2025
Price Band: ₹382 to ₹402 per share
Lot Size: 35 shares
Issue Size: ₹3,027.26 Crores
Fresh Issue: ₹300 Crores
Offer for Sale (OFS): ₹2,727.26 Crores
Retail Quota: 35%
GMP: Nil (for informational purposes only)
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matters published here are purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. Any reader making decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in the stock market is subject to unpredictable market-related risks. The author has no plans to invest in this offer and also the author does not recommend investing in any offer published on this website.